Back to Results
First PageMeta Content
Autoimmune diseases / Epratuzumab / Pharmacology / Immune system / Systemic lupus erythematosus / Trogocytosis / Anti-SSA/Ro autoantibodies / Yttrium (90Y) clivatuzumab tetraxetan / CD20 / Anatomy / Biology / Monoclonal antibodies


Microsoft PowerPoint - Corporate Presentation June 2014
Add to Reading List

Document Date: 2014-06-10 13:31:15


Open Document

File Size: 443,08 KB

Share Result on Facebook

Company

OLE Screen Week 24 Week 48 Week / IMMUNOMEDICS INC. / UCB / /

Country

United States / /

Currency

pence / USD / /

Event

FDA Phase / /

Facility

Broad Pipeline of Antibody‐Based Therapies Research/Preclinical Phase / /

MedicalCondition

Cancer‐Solid Tumors / difficult‐to‐treat tumors / Systemic lupus erythematosus / Randomization Minimum disease / cancer / SLE / advanced pancreatic cancer / Lupus / Immunology‐Lupus / pancreatic cancer / /

Organization

Congress / National Institute of Health / European Union / Securities and Exchange Commission / Harvard / /

Position

physician global assessment / Forward / Private / /

Product

CD22 / 2H14 / mid 2015 Antibody‐drug / 1Q15 / SLE / Antibody‐drug / /

SocialTag